CYTOVALE
Categorized is a medical technology company that revolutionizes diagnostics using cell mechanics and machine learning. The company was founded in 2013 by Ajay Shah and Dino Di Carlo and is based in San Francisco, California, United States.
CYTOVALE
Industry:
Artificial Intelligence Health Diagnostics Life Science Machine Learning
Founded:
2013-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.cytovale.com
Total Employee:
11+
Status:
Active
Contact:
562-881-6919
Email Addresses:
[email protected]
Total Funding:
44.59 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Apps For Business Google Maps Microsoft Azure DNS Cloudflare JS
Current Advisors List
Current Employees Featured
Founder
Investors List
Dolby Family Ventures
Dolby Family Ventures investment in Debt Financing - CytoVale
Breakout Ventures
Breakout Ventures investment in Debt Financing - CytoVale
Pathway Bioventures
Pathway Bioventures investment in Debt Financing - CytoVale
Blackhorn Ventures
Blackhorn Ventures investment in Debt Financing - CytoVale
Western Technology Investment
Western Technology Investment investment in Series B - CytoVale
Blackhorn Ventures
Blackhorn Ventures investment in Series B - CytoVale
Breakout Ventures
Breakout Ventures investment in Series B - CytoVale
GRIDS Capital
GRIDS Capital investment in Series B - CytoVale
GRIDS Capital
GRIDS Capital investment in Series B - CytoVale
Breakout Ventures
Breakout Ventures investment in Series B - CytoVale
Official Site Inspections
http://www.cytovale.com
- Host name: do-sfo2-poree-sabou.tep.cloud.db-ops.net
- IP address: 138.68.49.125
- Location: Santa Clara United States
- Latitude: 37.3417
- Longitude: -121.9753
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95051
More informations about "CytoVale" on Search Engine
CytoVale - Crunchbase Company Profile & Funding
Company Type For Profit. Contact Email [email protected]. Phone Number 562-881-6919. CytoVale is a medical technology company that focuses on advancing early detection …See details»
Cytovale
SAN FRANCISCO--(BUSINESS WIRE)--Cytovale, a medical diagnostics company focused on providing a faster, more insightful way to diagnose fast-moving and immune …See details»
How Cytovale Is Set To Transform The Fight Against Sepsis
Oct 13, 2021 Given the prevalence of sepsis, its devastating impact and the current lack of simple diagnostics, Cytovale’s technology has the potential to be transformational. But …See details»
Cytovale Secures $84 Million Series C to Advance …
SAN FRANCISCO, Nov. 15, 2023 /PRNewswire/ -- Cytovale ®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to …See details»
CytoVale - Funding, Financials, Valuation & Investors - Crunchbase
$128.6M. in funding over 9 rounds. Their latest funding was raised on Nov 15, 2023 from a Series C round. CytoVale is funded by 13 investors. Global Health Investment …See details»
Cytovale Secures $84 Million Series C to Advance …
Nov 15, 2023 Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated …See details»
Cytovale: A Breakthrough Tool in The Fight Against Sepsis
Nov 15, 2023 Our latest investment is in just such a company: Cytovale, a pioneering medical diagnostics company that’s focused on advancing early detection and treatment …See details»
Sepsis diagnostic company Cytovale raises $84M Series C - Axios
Nov 15, 2023 Diagnostics company Cytovale raised $84 million in Series C funding to commercialize its sepsis test, CEO Ajay Shah tells Axios. Why it matters: Sepsis is the …See details»
Cytovale - Business Wire
Aug 1, 2023 SAN FRANCISCO-- ( BUSINESS WIRE )-- Cytovale ®, a pioneering medical diagnostics company focused on advancing early detection technologies to diagnose …See details»
GHIC Invests in Cytovale’s Series C Financing
Nov 15, 2023 SAN FRANCISCO, CA / NEW YORK, NY, 15 November 2023: Cytovale ®, a pioneering medical diagnostics company focused on advancing early detection …See details»
CytoVale - Updates, News, Events, Signals & Triggers - Crunchbase
Feb 10, 2024 CytoVale, a medical diagnostics company, has made significant strides in early detection technology with its rapid sepsis diagnostic test. This innovation has …See details»
Cytovale Strengthens Leadership Team with Appointment of Dr.
Jul 23, 2023 Cytovale, a medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, has …See details»
Cytovale's Diagnostic Test Demonstrates Strong Performance in …
PR Newswire. Thu, May 2, 2024, 9:15 AM 3 min read. Large scale study confirms Cytovale's IntelliSep test accurately predicts sepsis risk and severity, aids in appropriate …See details»
Cytovale® Announces Commercial Launch of IntelliSep® Sepsis …
SAN FRANCISCO, August 01, 2023--Cytovale®, a pioneering medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving …See details»
CytoVale | VentureRadar
CytoVale | VentureRadar. Location: USA. Founded in 2013. Private Company. Develops a rapid system for assessing immune state and identifying disease signatures, with a …See details»
Cytovale's Rapid Sepsis Diagnostic Test Demonstrates Improved …
SAN FRANCISCO, March 19, 2024 /PRNewswire/ -- Cytovale ®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to …See details»
CytoVale - Contacts, Employees, Board Members, Advisors
Unlock even more features with Crunchbase Pro. CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune …See details»
Cytovale | Devex
About. A team of biologists, data scientists, and engineers developing mechanical biomarkers to improve human health. The novel microfluidic platform allows to probe …See details»